FDA Approves First New Weight Loss Pill in Decade

The agency cleared the pill for adults who are obese or are overweight with at least one medical complication

View Comments (
)
|
Email
|
Print

    NEWSLETTERS

    Dr. Ken Fujioka from Scripps Health explains to NBC 7 reporter Greg Bledsoe about how the new weight loss pill Belviq could work.

    The Food and Drug Administration has approved the San Diego company Arena Pharmaceutical anti-obesity pill Belviq, the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade.

    The agency cleared the pill for adults who are obese or are overweight with at least one medical complication, such as diabetes or high cholesterol.

    The Food and Drug Administration denied approval for Arena's drug in 2010 after scientists raised concerns about tumors that developed in animals studied with the drug. The San Diego company resubmitted the drug with additional data earlier this year, and the FDA said there was little risk of tumors in humans.

    FDA Approves Local Company Weight Loss Pill

    [DGO] FDA Approves Local Company Weight Loss Pill
    Dr. Ken Fujioka from Scripps Health explains to NBC 7 reporter Greg Bledsoe about how the new weight loss pill Belviq could work.

    With U.S. obesity rates nearing 35 percent of the adult population, many doctors have called on the FDA to approve new weight loss treatments.
     

    Follow NBCSanDiego for the latest news, weather, and events: iPad App | iPhone App | Android App | Facebook | Twitter | Google+ | Instagram | RSS | Text Alerts | Email Alerts